Zurich Cantonal Bank’s Tourmaline Bio TRML Stock Holding History

Zurich Cantonal Bank’s Portfolio TRML Stock Details TRML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,515	Closed	-$120K	–	3407
2025 Q3	$120K	Buy	+2,515	New	+$69.8K	﹤0.01%	2347
2022 Q4	–	Sell	-178	Closed	-$5K	–	2904
2022 Q3	$5K	Hold	178	–	–	﹤0.01%	2888
2022 Q2	$8K	Buy	+178	New	+$14K	﹤0.01%	2865

Zurich Cantonal Bank's TRML Position: Q4 2025 in Review

Zurich Cantonal Bank sold out of Tourmaline Bio (TRML) in Q4 2025, closing a stake of 2,515 shares — an estimated $120K sold.

Zurich Cantonal Bank first reported a position in TRML in Q2 2022 and held it in 3 quarters. The position peaked at $120K in Q3 2025. 0 funds tracked by Wall St. Rank hold TRML as of Q4 2025.

Zurich Cantonal Bank reported no remaining Tourmaline Bio position as of Q4 2025 after selling out during the quarter.
Zurich Cantonal Bank sold 2,515 Tourmaline Bio shares in Q4 2025, an estimated $120K.
Zurich Cantonal Bank first reported a position in Tourmaline Bio in Q2 2022 and held it in 3 quarters.
Zurich Cantonal Bank's Tourmaline Bio position peaked at $120K in Q3 2025.
0 funds tracked by Wall St. Rank held Tourmaline Bio as of Q4 2025.

Based on Zurich Cantonal Bank's 13F filing for Q4 2025, filed 27 Jan 2026.